Summary The purpose of this study was to determine whether power Doppler ultrasound techniques could be used to direct biopsies into tumour regions with relatively low red blood cell flux, and therefore preferentially sample regions that were relatively hypoxic. Subcutaneous 9L glioma rat tumours were biopsied using power Doppler ultrasound guidance. Immunohistochemical detection of the 2-nitroimidazole EF5 was performed to determine the presence and level of hypoxia in the biopsy samples. Comparisons between the power Doppler-determined red blood cell flux and EF5 binding were made. In seven out of eight tumours studied, power Doppler ultrasound allowed differentiation of a relatively hypoxic region from a relatively oxic region by localizing relatively low vs high red blood cell flux areas respectively. In one of these seven tumours, RBC flux was high in both biopsied sites and hypoxia was not present in either. In two of these seven tumours, hypoxia was present in each biopsy and both of the red blood cell flux measurements were low. In the eighth tumour, both the EF5 binding and the red blood cell flux measurements were low. In this tumour, low EF5 binding was due to the dominance of necrotic cells, which will not reduce or bind EF5 in the biopsy specimen. Using EF5-binding techniques, we have confirmed that regions of relatively low red blood cell flux are more hypoxic than those with relatively high red blood cell flux. Counterstaining specimens with haematoxylin and eosin allows differentiation of low EF5-binding regions due to oxia vs necrosis. These methods have clinical implications for the expanded use of power Doppler ultrasound as a means to direct tissue sampling when it is important to identify the presence of hypoxia.
Heterogeneity is one of the most common and clinically important characteristics of tumours. Heterogeneity has been categorized as either clonal, related to genetic aspects of tumour biology, or secular, related to microenvironmental aspects (Heppner, 1984; Heppner and Miller, 1989) . A major determinant of secular heterogeneity is the tumour vasculature. Because tumour blood vessels cannot grow as rapidly as the neoplastic tissues, the resulting vasculature is disorganized and inefficient. Elegant window chamber studies by Secomb et al (1993) have demonstrated that tumour vasculature is characterized by the presence of arteriovenous shunting, sinusoid formation, plasma flow in the absence of red blood cell (RBC) flow and flow of deoxygenated RBCs. These characteristics, interacting with the variable metabolic consumption of tumour and host cells, result in the presence of microenvironments that include hypoxia (Vaupel et al, 1989) . Hypoxic microenvironments have been shown to be associated with poor prognosis and treatment response. For example, the presence of hypoxia in human tumours, assessed using the Eppendorf polarographic needle electrode, has been correlated with metastasis in soft tissue sarcomas (Brizel et al, 1996) and local-regional recurrence in cervical carcinoma after surgery or radiation therapy (Hockel et al, 1996) .
One of the difficulties in measuring tumour tissue oxygenation is sampling error. This problem is particularly relevant to the accuracy of hypoxia determination using needle electrodes and biopsy-based measurement techniques, including the Comet assay (Olive et al, 1990 ) and nitroimidazole binding (Koch et al, 1995; Evans et al, 1996) . The presence of hypoxia is an indicator of poor prognosis and patients with hypoxic tumours require specialized, aggressive and expensive therapy. Examples include treatment with hypoxic cytotoxins (Lee et al, 1996) , vasoactive agents in combination with changes in radiation fractionation and inhaled oxygen (ARCON; Rojas, 1992) , radiation sensitizers (Huilgol et al, 1996) and hyperthermia (Oleson, 1995) . As inaccurate assessments of the presence of hypoxia would be very deleterious to the patient, any technique that would aid accurate sampling of hypoxic regions should improve patient care. In this report, we suggest the use of power Doppler ultrasound to augment the accuracy of hypoxia assessment.
Power Doppler ultrasound has been described for use in clinical medicine by Rubin et al (1994) . The application of this technique is primarily in the evaluation of blood flow. The hue and brightness of the colour signal representing the power of the Doppler spectrum is related to the number of RBCs, e.g. RBC flux, producing the Doppler shift. This technique is well suited to evaluate tumour blood flow because it is more sensitive to lower velocity blood flow than colour Doppler techniques (Eriksson et al, 1991) . As hypoxia is primarily a result of low or ineffective tumour blood flow (Vaupel et al, 1989) , we hypothesized that ultrasound Doppler techniques could be used to direct biopsies into tumour regions with the lowest relative blood flow, and these regions were likely to be relatively hypoxic.
We have investigated this hypothesis in the 9L glioma tumour grown subcutaneously in Fischer rats. Using nitroimidazolebinding techniques, specifically the 2-nitroimidazole EF5 with (Leith et al, 1975; Wallen et al, 1980) . These cells were originally obtained from Dr KT Wheeler (Bowman Gray School of Medicine, Winston Salem, NC, USA). All animal studies were performed under the regulations provided by the University of Pennsylvania Institutional Animal Care and Use Committee. 9L tumours were grown by transferring 1-3 mg pieces of tumour into the subcutaneous space over the thigh musculature of male Fischer rats weighing 200-250 g. All tumours used were of late passage (> 6) which, based upon our previous studies, have a high probability of containing radiobiologically significant hypoxia [(Evans et al, 1996) , other data not shown]. All tumours were between 2 and 4 cm maximum diameter.
Ultrasound and Doppler studies
The hair overlying the tumour region was shaved and the rat was positioned in sternal recumbency for ultrasound examination and tumour biopsy. Tumour images were acquired using grey scale imaging and power Doppler techniques on an ATL Ultramark 9HDI scanner (ATL, Bothell, WA, USA). The imaging was performed using a 10-5 transducer. A low wall filter (less than 50-Hz) was used throughout the study to maximize visualization of low RBC flux.
Grey scale images were initially made to determine the extent and patterns of echogenic heterogeneity and, when possible, to identify regions that were likely to be necrotic. Colour and power Doppler studies were then performed to map RBC flux. Two or three ultrasound Doppler-guided biopsies were made in each tumour, with the emphasis on directing biopsies to regions with the relatively lowest vs highest RBC flux. Careful attention was paid to using a large amount of ultrasound gel to couple the transducer to the tumour surface, and to avoid surface pressure that could modify blood flow in the tumour. After studying three tumours, it became apparent that the information obtained from Figure 1 . A is a biopsy from a region of relatively high, diffuse RBC flux, whereas B represents a biopsy from the region of low RBC flux, adjacent to the distinct blood vessel seen in Figure 1 . Both sections are 4x magnification and the photographs exposed for the same amount of time regions that were immediately adjacent to the ultrasound transducer (to a depth of approximately 5 mm) did not reliably reflect the presence or absence of RBC flux. This conclusion was reached because when the tumour was scanned from various directions different assessments of flux were obtained from the regions that were adjacent to the transducer. However, regions deeper than 5 mm from the transducer surface were consistent in their ultrasound Doppler characteristics. Use of a tissue equivalent stand-off was attempted but there was concern that the pressure from the stand-off could modify blood flow. In addition, it was technically impossible to direct accurately biopsies with the stand-off in place. Therefore, biopsies obtained from the most superficial tumour regions were not included in the analyses.
Images were recorded on tape and analysed by a computerized method based on semi-automated vessel counting of the power Doppler images. The videotaped images were digitized frame by frame at 8-bit resolution using a frame grabber (Nuvista+, (Lord et al, 1993) . The antibodies used in the present study are from a single hybridoma clone, designated as ELK3-51. The monoclonal antibodies were conjugated with the green-excited, orange-emitting fluorescent dye, Cy3 (Southwick et al, 1990 ). This dye is available in an amine reactive form from Amersham (Arlington Heights, IL, USA).
Hypoxic marker tumour biopsy studies
Tumour-bearing rats were given EF5 as an intravenous injection of 10 mm solution prepared in 0.9% saline. The mass of solution administered was 1% of the animal's mass and the resulting equivalent whole-body concentration was 100 gM. Two hours after EF5 administration, the animal was anesthetized with intraperitoneal injections of xylazine (1.3 mg kg-') and ketamine (140 mg kg-'). The hair overlying the tumour region was shaved and the animal positioned for ultrasound examination and tumour biopsy. After detailed ultrasound examination using grey scale and Doppler techniques, two to three guided biopsies were obtained using a 14 G semiautomatic biopsy device (COOK Veterinary Products, Bloomington, IA, USA). The resulting biopsies were between 5 and 15 mm in length and approximately 1.5 mm in diameter. Biopsies were placed on moistened filter paper and rapidly frozen by placing the filter paper on dry ice. The specific orientation of each biopsy piece relative to the tumour surface was documented by painting India ink on the portion of the biopsy that corresponded to the most superficial tumour surface. After completion of the biopsy procedure, the tumour was removed and weighed; the portion of the tumour that contained the biopsy tracts was frozen for further immunohistochemical and histopathological analyses (Evans et al, 1995) .
Whole tumour and core biopsy tissue sections were cut at 14 gm thickness using a Microm HM 505N cryostat and collected onto poly-L-lysine-coated microscope slides, as described previously (Evans et al, 1995) . Briefly, the sections were fixed for 1 h at 4°C in 4% paraformaldehyde in Dulbecco's phosphate-buffered saline (PBS), and rinsed twice in 1 x PBS. The tissue sections were then blocked against non-specific binding at 40C overnight. After removing the blocking solution, the slides were rinsed and ELK3-51 antibody conjugated to Cy-3 was added (75 ,ug m-') for 4-6 h at 40C. The slides were rinsed three more times and stored in I x PBS with 1% paraformaldehyde until photographed, usually within three days. At each step, the exchange of solutions was accomplished by moving the tissue-containing slide from container to container.
The tissue sections were analysed by measuring the fluorescence of the anti-EF5 monoclonal antibodies using a Zeiss fluorescence microscope fitted with a sensitive digital camera (Xillix, Vancouver, BC, Canada). The biopsy sample sections were imaged in their entirety and the whole tumour sections were imaged using representative regions. After photography of EF5 binding, slides were stained with haematoxylin and eosin and evaluated under a light microscope for the identification and differentiation of viable tumour tissue from areas with pyknosis, necrosis or acellularity.
Image analysis
To make the fluorescence evaluation as quantitative as possible and to allow comparison from sample to sample, it was necessary to measure the absolute fluorescence intensity of the regions of interest. Day-to-day variations in the lamp intensity were accounted for by filling the well of a haemocytometer with a reference concentration of Cy3 dye (a concentration with absorbance of 0.42 at 549 nm), then imaging the haemocytometer well while focusing on the gridlines. Variations in the fluorescence intensity of the reference dye (typically a factor of up to four during the life of a quartz-halogen bulb) were then used to adjust the intensities of the section images. In principle, this calibration would also correct for variations in camera sensitivity, but we have no reason to believe that camera sensitivity is not constant.
The section images were photographed so that the maximum pixel intensities were within the linear range of the camera (0-255). Two camera variables are set by the software; the camera sensitivity (S; varying from 1/256 to 1/4048 in factors of 2) and the camera exposure time (T; varying from less than 100 ms to 10 000 ms). Therefore, each pixel intensity is corrected by the factor (S/4096 x 10 000/T). The corrected pixel intensities of each image are divided by the median corrected pixel intensity of the haemocytometer calibration standard to determine the final fluorescence intensities.
Data analyses
Analyses of the relationship between the percentage of coloured pixels and EF5 binding were performed. Because of the large standard deviations associated with the mean values (representing the large contrast between oxic and hypoxic regions in the biopsy specimens), the median EF5 values were correlated with the pixel analyses.
RESULTS
Nine tumours in eight rats were studied with ultrasound and biopsy (one rat had a bilobed tumour and each segment was studied separately). The tumours ranged from 2 to 4 cm in maximum diameter. In one tumour, the biopsies became damaged during freezing and were not evaluated further. Biopsies from eight tumours were analysed for median EF5 binding as a marker of hypoxia and the percentage of coloured pixels as a measure of regional tumour red blood cell flux. Figure 3 . In both photomicrographs, a distinct pattern of hypoxia can be seen: there is a central oxic region surrounding blood vessels (no EF5 binding) followed by viable hypoxic cells and, in some areas, more distant necrotic cells. This pattern was first described by Thomlinson and Gray (1955) Figure lB and C was made using power ultrasound Doppler techniques and these data are presented as regions of flow (colour) superimposed on the appropriate prebiopsy (1B) or post-biopsy (1C) greyscale images. The sites where two biopsy samples were taken (no. 1 and no. 2) are seen in Figure IC . The deeper biopsy (no. 1) was made several millimetres superficial to an ultrasonographically identifiable blood vessel and the more superficial biopsy (no. 2) was made in a region in which vascular flux is seen over a larger and less well-defined tissue region. The hyperechoic biopsy track can be reliably identified because of the air remaining there. Figure ID Figure 2A and B demonstrates the EF5 binding in the specimens made in the sample sites described for Figure 1 , above. Figure 2A represents biopsy sample no. 2 with 26% coloured pixels and 19.3 median EF5 binding. Figure 2B is biopsy sample no. 1, which contained a lower percentage of coloured pixels (11.3%) and higher median EF5 binding (41.8) .
Tumour no. 960510-1 was sectioned in detail and the whole tumour sections from which the biopsies were removed were stained for EF5 binding and restained with haematoxylin and eosin. Figure 3 shows the gross appearance of one biopsy and the whole tumour section from which it was removed. Portions of the whole tumour section contain viable tumour cells (Figure 4 ) that have a distinct pattern of hypoxia ( Figure 5A) ; there are central oxic regions (no EF5 binding) adjacent to regions of viable hypoxic cells and in some areas, more distant necrotic cells ( Figure  5A and B). Blood vessels can be seen as dark circular regions in the middle of the non-binding, oxic regions. Some aspects of the tumour contain necrotic regions (Figure 4 ) and EF5 binding cannot be seen in these necrotic regions ( Figure 5A and B) . There is good correspondence between the histological and immunohistochemical appearance of the whole tumour section and the biopsy section.
To determine whether Doppler ultrasound estimates of relative low RBC flux could guide biopsies to regions corresponding to hypoxia, a comparison was made between the percentage of coloured pixels and median EF5 binding in eight tumours ( Figure  6 ). In seven out of eight tumours studied, the relationship between the percentage of coloured pixels and median binding was negatively correlated, as predicted. 
DISCUSSION
In recent years, the inter-relationship and clinical importance of tumour clonal and secular heterogeneity has become increasingly apparent. Genetic characteristics of tumours, such as up-regulation of oncogenes (p53), gene products (VEGF) and metastatic potential have been associated with hypoxic tumour microenvironments (Graeber et al, 1996; Mazure et al, 1996) . The documentation that hypoxia has a major impact on the biology, physiology, clinical behaviour and treatment response of human tumours has increased in recent years. This has primarily been the result of the increased ability to measure tissue hypoxia in situ using a variety of techniques (Stone et al, 1993) . Three methodologies are in the forefront of this effort: the Comet assay (Olive et al, 1990; , needle electrode measurements (Gatenby et al, 1988; Hockel et al, 1991; Brizel et al, 1996) and 2-nitroimidazole-binding techniques (Hodgkiss et al, 1991; Cline et al, 1994; Evans et al, 1995; Koch et al, 1995) . Recent studies using the Eppendorf needle electrode in humans, have documented the association of hypoxia with local recurrence of cervical carcinoma after surgery or radiation therapy (Hockel et al, 1996) and metastasis of soft tissue sarcoma (Brizel et al, (Evans et al, 1996; Woods et al, 1996) and the response to drug therapies that modify tissue oxygen content (Lee et al, 1996) .
Power Doppler ultrasound studies were proposed herein because of the expected relationship between tissue oxygenation and tumour blood flow. Previous studies in non-neoplastic diseases of muscle (Newman et al, 1994) and kidney have supported the notion that power Doppler ultrasonography facilitates the evaluation of tissue perfusion. The current applications of ultrasound in the field of oncology are limited to tumour detection and staging [for example, see (Lindmark et al, 1992) ] and to aid the placement of biopsies into regions of abnormal grey scale echogenicity [for examples, see (Fomage et al, 1992; Parker et al, 1993; McCombs et al, 1995) (Alexander et al, 1996) . We were unable to find any previous studies that used Doppler techniques to assess the relative presence and distribution of hypoxia in tumours.
The aims of the studies herein were to determine whether ultrasound, an easily available, inexpensive and non-invasive imaging technique, could be used to direct biopsies into regions in which there was minimal blood flow and, therefore, hypoxia. There was no expectation that ultrasound-based endpoints would correlate directly with tumour hypoxia because it is clear, based upon physiological principles, that red blood cell flux is only one of several parameters that influence tissue oxygenation; parameters including tissue respiration rate, blood oxygen carrying capacity, haematocrit and microscopic blood flow distributions cannot be accounted for in the ultrasound images. We have previously shown that EF5 binding does correlate with tumour hypoxia and radiation resistance (Evans et al, 1995) . It was therefore hypothesized that relative variations in the percentage of coloured pixels would predict variations in EF5 binding in individual tumours. This hypothesis is confirmed by the data shown in Figure 6 . The optimal relationship between the measured parameters of blood flow (the percentage of coloured pixels on power Doppler studies) and hypoxia (median EF5 binding) would be a high negative correlation; herein seven out of eight tumours studied showed this optimal relationship (Figure 6) . It is not possible from these data to be certain that the specimen obtained in this manner was the most hypoxic tumour region. However, based upon the comparison of the biopsies to the whole specimen in one tumour (Figure 5 ), the biopsy samples reflect the distribution of hypoxia in the rest of the tumour. Based upon our previous studies (Evans et al, 1996) , the radiation response in the 9L tumour is based upon the presence of moderately, not severely hypoxic tumour cells. Whether this holds true in human tumours remains to be seen. However, this is likely because severely hypoxic tumour cells are unlikely to be clonogenic.
Despite the confirmation of our hypothesis, there is clearly more room for technique improvement and further development. For example, the transducer used in the present study was relatively large in size, intended for species larger than rats. More accurate information may be obtained with the use of a smaller and more sensitive transducer or performing studies in dogs and cats with spontaneous tumours, or humans. Similarly, we have not optimized the machine settings for tumour measurements. Instead, we chose to use a constant setting of the ultrasound machine based on normal tissue applications. We will be investigating these aspects of technique improvement using models in which absolute blood flow can be determined independently, e.g. a tissue isolated tumour model (Evans et al, 1995) . In addition, we have not quantitated the effects of intratumoral blood flow heterogeneity on the sensitivity and specificity of the ultrasound images. It is probable that a number of blood cell scatterers and velocities are below the threshold necessary to be detected using the power Doppler technique and we may require the use of contrast agents to enhance the detection of lowest flow regions (Forsberg et al, 1995; Sehgal et al, 1995) . These agents are designed to increase the number of scatterers in the vessels, increasing Doppler sensitivity to flow.
In the tumours studied herein, several regions of several colour Doppler images contained no coloured pixels. Biopsies from these areas consistently showed high EF5 binding and in one tumour, necrosis. The highest level of EF5 binding was found in a biopsy with 12% coloured pixels (tumour 960216-1; 0 Figure 6 ). Physiologically, this may reflect blood flow in long vessels carrying primarily deoxygenated blood (Secomb et al, 1993) . Alternatively, the respiration rate or tissue cellularity of this tumour may have been higher than in other specimens. Inverse arguments may be made for the finding of relatively low EF5 binding and low fractional coloured pixels in biopsies from 960412-8 and 960723-8 (A, A Figure 6 ). In future studies we will apply more sophisticated analysis methods to the EF5-binding assay as 'median' binding may be inferior to endpoints such as threshold values or assessments of heterogeneity.
To summarize, we believe that the use of ultrasound guidance for the selection of regions of relatively low flow and relatively low tissue oxygenation is a promising new technique to augment the sampling of hypoxic tumours. It should be useful for any of the British Journal of Cancer (1997) 76(10), [1308] [1309] [1310] [1311] [1312] [1313] [1314] oxygen detection methods currently being developed that rely on sampling techniques (i.e. Comet assay, needle electrode measurement, nitroimidazole binding). The use of ultrasound contrast agents and harmonic imaging (Burns 1996) 
